UNIGE document Scientific Article
previous document  unige:19892  next document
add to browser collection
Title

Modified tumour antigen-encoding mRNA facilitates the analysis of naturally occurring and vaccine-induced CD4 and CD8 T cells in cancer patients

Authors
Knights, Ashley J.
Nuber, Natko
Thomson, Christopher W.
de la Rosa, O.
Jager, E.
van den Broek, M.
Pascolo, S.
show hidden authors show all authors [1 - 10]
Published in Cancer Immunology, Immunotherapy. 2009, vol. 58, no. 3, p. 325-338
Abstract The development of effective anti-cancer vaccines requires precise assessment of vaccine-induced immunity. This is often hampered by low ex vivo frequencies of antigen-specific T cells and limited defined epitopes. This study investigates the applicability of modified, in vitro-transcribed mRNA encoding a therapeutically relevant tumour antigen to analyse T cell responses in cancer patients. In this study transfection of antigen presenting cells, by mRNA encoding the tumour antigen NY-ESO-1, was optimised and applied to address spontaneous and vaccine-induced T cell responses in cancer patients. Memory CD8+ T cells from lung cancer patients having detectable humoral immune responses directed towards NY-ESO-1 could be efficiently detected in peripheral blood. Specific T cells utilised a range of different T cell receptors, indicating a polyclonal response. Specific killing of a panel of NY-ESO-1 expressing tumour cell lines indicates recognition restricted to several HLA allelic variants, including a novel HLA-B49 epitope. Using a modified mRNA construct targeting the translated antigen to the secretory pathway, detection of NY-ESO-1-specific CD4+ T cells in patients could be enhanced, which allowed the in-depth characterisation of established T cell clones. Moreover, broad CD8+ and CD4+ T cell responses covering multiple epitopes were detected following mRNA stimulation of patients treated with a recombinant vaccinia/fowlpox NY-ESO-1 vaccine. This approach allows for a precise monitoring of responses to tumour antigens in a setting that addresses the breadth and magnitude of antigen-specific T cell responses, and that is not limited to a particular combination of known epitopes and HLA-restrictions.
Keywords Antibodies, Monoclonal/chemistryAntigens, Neoplasm/chemistry/*metabolismCD4-Positive T-Lymphocytes/*metabolismCD8-Positive T-Lymphocytes/*metabolismCancer VaccinesCarcinoma, Non-Small-Cell Lung/metabolismCell Line, TumorEpitopes/chemistryHumansInterferon-gamma/metabolismLung Neoplasms/metabolismModels, GeneticNeoplasms/*blood/*metabolismPeptides/chemistryRNA, Messenger/*metabolism
Identifiers
PMID: 18663444
Full text
Structures
Research group Compatibilité tissulaire et transplantation clinique (562)
Citation
(ISO format)
KNIGHTS, Ashley J. et al. Modified tumour antigen-encoding mRNA facilitates the analysis of naturally occurring and vaccine-induced CD4 and CD8 T cells in cancer patients. In: Cancer Immunology, Immunotherapy, 2009, vol. 58, n° 3, p. 325-338. https://archive-ouverte.unige.ch/unige:19892

236 hits

0 download

Update

Deposited on : 2012-04-23

Export document
Format :
Citation style :